Pages that link to "Q37126642"

The following pages link to Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models (Q37126642):

Displaying 29 items.

• Immune Checkpoint Blockade: A New Paradigm in Treating Advanced Cancer (Q26795509) (← links)
• Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy (Q26796309) (← links)
• Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity (Q26862220) (← links)
• Advances in the understanding of cancer immunotherapy (Q27000706) (← links)
• Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma (Q28069864) (← links)
• COEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH) (Q28818101) (← links)
• The role of checkpoints in the treatment of GBM (Q36571197) (← links)
• Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model. (Q37482728) (← links)
• Immunotherapy and lung cancer: current developments and novel targeted therapies (Q38286376) (← links)
• Immunotherapy in lung cancer (Q38390093) (← links)
• IL-21: a pleiotropic cytokine with potential applications in oncology (Q38471387) (← links)
• Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer. (Q38527538) (← links)
• Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms (Q38699858) (← links)
• Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth. (Q38722809) (← links)
• Checkpoint inhibition for colorectal cancer: progress and possibilities (Q38838641) (← links)
• Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck (Q38855031) (← links)
• Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial. (Q39141902) (← links)
• The molecular basis of breast cancer pathological phenotypes (Q39175548) (← links)
• Immune checkpoints and immunotherapy for colorectal cancer (Q40383388) (← links)
• Tumor location impacts immune response in mouse models of colon cancer (Q41550721) (← links)
• Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models. (Q42288675) (← links)
• Combining DNA damaging therapeutics with immunotherapy: more haste, less speed. (Q47621538) (← links)
• The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis (Q58698737) (← links)
• Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis (Q59791950) (← links)
• Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with immune checkpoint inhibitors: A systematic review and meta-analysis (Q64298027) (← links)
• Cancer immunotherapy: broadening the scope of targetable tumours. (Q64931054) (← links)
• Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model (Q86757302) (← links)
• The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome (Q89286757) (← links)
• Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors (Q90451070) (← links)